Susie Lisa

Susie Lisa is Senior Vice President, Investor Relations (IR), for Vertex Pharmaceuticals, having joined in September 2022. Previously, she worked for more than a decade in investor relations for leading health care companies in the New England region, including Boston Scientific, CVS Health, and Abiomed. Under her leadership, the Vertex IR program and IR team were ranked #1 overall in Biotechnology by Institutional Investor for 2023-2024. At Boston Scientific, the IR team was also ranked #1 overall by Institutional Investor in its sector, including best Investor Relations program and best communication of strategy and risk management amid COVID-19. In 2019, Susie was named by IR Magazine as Best Investor Relations Officer (large cap, across all sectors).

Prior to her investor relations experience, Susie spent over twenty years in a variety of Wall Street-related roles, including 12 years at Bank of America Merrill Lynch, where she was a Managing Director and Head of Americas Specialist Sales with a focus in healthcare equity research sales. She also has worked at Cowen & Co. and JPMorgan Chase as an equity research analyst in the medical device sector, in healthcare investment banking, and in convertible bond sales. She earned a BA in Economics and Political Science from Duke University and an MBA in Finance from New York University – Stern School of Business and is a CFA charter holder.

Susie and her husband, Tony, live in Sudbury, Massachusetts with their three children (all in college) and two Labrador retrievers.